OneMedNet Co. (NASDAQ:ONMD) Short Interest Down 36.1% in February

OneMedNet Co. (NASDAQ:ONMD) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 71,500 shares, a decrease of 36.1% from the February 13th total of 111,900 shares. Based on an average daily trading volume, of 138,600 shares, the short-interest ratio is presently 0.5 days. Approximately 0.5% of the shares of the company are short sold.

OneMedNet Stock Performance

NASDAQ:ONMD traded down $0.01 during midday trading on Friday, reaching $0.69. The stock had a trading volume of 16,846 shares, compared to its average volume of 2,044,451. OneMedNet has a 1-year low of $0.46 and a 1-year high of $3.37. The firm’s fifty day simple moving average is $1.00 and its 200-day simple moving average is $0.93.

OneMedNet (NASDAQ:ONMD) last issued its quarterly earnings results on Tuesday, December 17th. The company reported ($0.08) earnings per share (EPS) for the quarter.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ONMD. XTX Topco Ltd increased its position in OneMedNet by 280.3% during the third quarter. XTX Topco Ltd now owns 41,683 shares of the company’s stock worth $25,000 after acquiring an additional 30,723 shares during the period. Virtu Financial LLC raised its position in shares of OneMedNet by 160.1% during the fourth quarter. Virtu Financial LLC now owns 32,389 shares of the company’s stock valued at $44,000 after buying an additional 19,938 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of OneMedNet by 49.6% in the fourth quarter. Geode Capital Management LLC now owns 152,937 shares of the company’s stock valued at $208,000 after buying an additional 50,690 shares during the period. 0.95% of the stock is owned by institutional investors.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.